Delivery Order 36C25519D0035-36C25522N0363

Award Date 7/30/22
Potential Completion Date 7/29/23
Potential Value $170K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oakland, CA 94608, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, to provide cost-per-test blood analyzers. The $180,856.87 contract has a completion date of July 29, 2021 and does not utilize a set-aside designation. Grifols Diagnostic Solutions is a division of the global healthcare company Grifols, which has received over $8 million in federal awards as a prime contractor for supplying critical...
This federal contract award to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, provides the Department of Veterans Affairs (VA) with cost-per-test blood analyzers. The $182,003.43 firm-fixed-price delivery order has a completion date of July 29, 2022. Grifols, a global healthcare company, has received over $8 million in prior federal awards to supply critical medical laboratory equipment and supplies, including reagents, testing kits, blood analyzers, and associated...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, under a $1.25 million Indefinite Delivery/Indefinite Quantity (ID/IQ) contract for Critical Analyzers and Laboratory Equipment. The $164,125.81 firm fixed-price award is for the exercise of "Option Year 4" (OY4) of the contract, providing Grifols Bloodbank Reagents to the VA's Veterans Integrated Service Network 15. The award does...
This is a federal contract awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit subsidiary of the global healthcare company Grifols. The $33,623.65 firm-fixed-price contract is for the provision of blood bank reagents through a Blanket Purchase Agreement (BPA) call under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. The contract supports the VA's Integrated Service Network 15 and does not...
This contract was awarded by the Veterans Integrated Service Network 7, a civilian agency under the Department of Veterans Affairs, to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company. The $347,820.44 fixed-price delivery order is for an Automated Blood Bank Testing System, which supports critical medical laboratory operations at VA medical facilities. The contract was issued against Grifols' existing General Services Administration (GSA) Schedule 65-VII for In Vitro...
This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned, for-profit organization, for the supply of blood bank reagents. The contract, valued at $4,289.78, has an ultimate completion date of May 31, 2025 and was awarded on June 1, 2022. The contract is a Blanket Purchase Agreement (BPA) call under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. Grifols, a global...
This firm-fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, to provide reagents. The $133,042.35 contract has a performance period ending on September 30, 2020 and does not utilize a set-aside. Grifols is a global healthcare company that supplies critical medical laboratory equipment, supplies, and services such as blood analyzers, automated gel testing...
This is a federal contract awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, to provide BLOOD REAGENTS AND SUPPLIES. The contract is a firm-fixed-price Purchase Order with a ceiling value of $855,495.10 and a performance period through September 30, 2025. Grifols Diagnostic Solutions Inc. is a division of the global healthcare company Grifols and has received over $8 million in prior federal awards as a prime contractor...
This is a firm-fixed-price BPA call contract awarded to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 for the supply of blood bank reagents. The contract has a ceiling value of $3,263.42 and a period of performance through May 31, 2025. The award is under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets, which enables the VA to issue additional...
This is a delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company. The $40,941.33 firm-fixed-price contract is for the provision of cost-per-test blood analyzers. The contract has no set-aside designation and is scheduled for completion by January 29, 2025. Grifols Diagnostic Solutions Inc. is a division of the global healthcare company Grifols, and has received over...
  • 36C25519D0035
    Indefinite Delivery Contract
  • 36C25519D0035-36C25522N0363
    Delivery Order

The Department of Veterans Affairs (VA) awarded a $169,877.21 firm-fixed-price delivery order to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for blood bank automated reagents. The order was issued under the company's existing $1.25 million Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with the VA for critical analyzers and laboratory equipment, which was awarded through the General Services Administration (GSA) Schedule 66-III. Grifols Diagnostic Solutions Inc. is a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services to the federal government through numerous contracts. This delivery order does not have a set-aside designation and is intended to support VA medical centers with blood screening, donor testing, and diagnostics for infectious diseases. The contract has an ultimate completion date of July 29, 2023.

Generated 8/18/24, 12:51 AM